Increase/Decrease in Cash: The total change in cash for the company over the given period.
Bicara Therapeutics Inc. (BCAX) had Increase/Decrease in Cash of $-393.03M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-137.95M |
|
-- |
|
-- |
|
$155.60M |
|
$-155.60M |
|
$17.87M |
|
$-137.73M |
|
$-137.73M |
|
$-137.95M |
|
$-137.95M |
|
$-137.95M |
|
$-137.95M |
|
$-155.60M |
|
$-155.20M |
|
54.68M |
|
54.68M |
|
$-2.52 |
|
$-2.52 |
|
| Balance Sheet Financials | |
$422.05M |
|
$0.33M |
|
$8.94M |
|
$430.99M |
|
$28.95M |
|
-- |
|
$0.59M |
|
$29.54M |
|
$401.45M |
|
$401.45M |
|
$401.45M |
|
56.60M |
|
| Cash Flow Statement Financials | |
$-106.83M |
|
$-318.45M |
|
$32.26M |
|
$489.71M |
|
$96.69M |
|
|
Increase/Decrease in Cash |
$-393.03M |
$15.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-107.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.36% |
|
-34.36% |
|
-32.01% |
|
-34.36% |
|
$7.09 |
|
$-1.96 |
|
$-1.95 |
|